Diabetes-induced suppression of IGF-1 and its receptor mRNA levels in rat superior cervical ganglia

Milad Sami Bitar, Charles W.T. Pilcher, Islam Khan, Robert J. Waldbillig

Research output: Contribution to journalArticle

37 Citations (Scopus)


Insulin-like growth factor-I (IGF-I) is implicated in the development, survival and maintenance of function of sympathetic and sensory neurons. These neurons are affected at an early stage during the course of diabetes. Reverse transcriptase polymerase chain reaction (RT-PCR) based assay revealed that rat superior cervical ganglia (SCG) express mRNA transcripts for IGF-I and its receptor. Moreover, specific membrane protein binding sites of IGF-I within the SCG have also been demonstrated using competition-inhibition and affinity cross-linking techniques. An induction of diabetes with streptozotocin (STZ, 55 mg/kg, i.v.) produced a marked decrease in the SCG levels of mRNA transcripts for IGF-I and its receptor. Concentrations of circulating IGF-I and its receptor protein within the SCG were also reduced in this disease state. Insulin treatment partially prevented diabetes- related alterations in circulating IGF-I and the SCG-IGF-I system. Overall, the data described in this study may be of value in understanding the pathogenetic mechanisms(s) responsible for the development of diabetic sympathetic neuropathy.

Original languageEnglish
Pages (from-to)73-80
Number of pages8
JournalDiabetes Research and Clinical Practice
Issue number2
Publication statusPublished - 1 Nov 1997



  • Diabetes mellitus
  • IGF-I
  • IGF-I receptor
  • Superior cervical ganglia

Cite this